Antimikrobiyal dirençle mücadelede yeni stratejiler: İmidazol içeren moleküllerin antibakteriyel potansiyeli

Öz

Hastalıklar hem doğal hem de sentetik kaynaklı ilaçlarla tedavi edilirken tedavilerde kullanılan ilaçların büyük çoğunluğunu sentetik ilaç formülasyonları oluşturmaktadır. Enfeksiyon hastalıklarına neden olan mikroorganizmaların tedavisinde antibiyotiklerin bilinçsizce kullanılması, çoklu ilaca dirençli bakteriler de dahil olmak üzere yeni direnç mekanizmalarının ortaya çıkmasına neden olmuştur. Dünya Sağlık Örgütü’ne göre günümüzde ve yakın gelecekte karşılaşılabilecek en ciddi sağlık sorunlarından biri de antimikrobiyal dirençtir. Bu sorunun bertaraf edilebilmesi için farklı antimikrobiyal etki mekanizmalarına sahip yeni ilaç adaylarının keşfedilmesi önem arz etmektedir. Bu yüzden, önemli antibakteriyel özellikleriyle bilinen farklı heterosikliklerin yanısıra önemli antibakteriyel etkileri olan ve yapısında bir ya da daha fazla azot atomu bulunan beş üyeli heterosiklik yapılardan olan imidazol halkasını taşıyan yeni ilaç adaylarının geliştirilmesi ve pazarlanması önemlidir. Araştırmacılar, son yıllarda yapısında imidazol halkası ve önemli heterosiklik yapılar taşıyan bileşikler tasarlayıp sentezlemiş ve bunların antibakteriyel etkilerini mevcut ilaçlara karşı direnç geliştirmiş olan çeşitli Gram negatif ve Gram pozitif bakterilere karşı araştırmıştır. Bu çalışmada, antimikrobiyal dirence neden olan faktörler, heterosiklik bileşiklerin bu direnci ortadan kaldırmadaki rolü ve son beş yılda (2020-2024) sentezlenen imidazol halkası içeren moleküllerin antibakteriyel aktiviteleri değerlendirilmiştir.

Anahtar Kelimeler

• Antimikrobiyal direnç
• antibakteriyel
• heterosiklik bileşikler
• imidazole türevleri

New strategies in combating antimicrobial resistance: Antibacterial potential of imidazole-containing molecules

Öz

Diseases are treated with pharmaceuticals derived from both natural and synthetic sources, with synthetic formulations predominating. The indiscriminate use of antibiotics in treating microorganisms responsible for infectious diseases has resulted in the emergence of novel resistance mechanisms including multidrug-resistant bacteria. The World Health Organization identifies antimicrobial resistance as one of the most critical health challenges currently and in the foreseeable future. To resolve this issue, it is essential to identify novel medication candidates with diverse antibacterial modes of action. Therefore, it is essential to develop and promote novel drug candidates containing the imidazole ring, a five-membered heterocyclic structure featuring one or more nitrogen atoms, alongside various heterocycles recognized for their notable antibacterial efficacy. In recent years, researchers have designed and synthesized molecules containing imidazole rings and significant heterocyclic structures, examining their antibacterial efficacy against diverse Gram-negative and Gram-positive bacteria that have acquired resistance to current pharmaceuticals. This study evaluates the factors contributing to antimicrobial resistance, the function of heterocyclic compounds in combating this resistance, and the antibacterial properties of imidazole ring-containing molecules synthesized in the past five years (2020-2024).

Anahtar Kelimeler

• Antimicrobial resistance
• antibacterial
• heterocyclic compounds
• imidazole derivatives

Kaynakça

1. Salam MA, Al-Amin MY, Salam MT, et al. Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare. 2023;11(13)doi:10.3390/healthcare11131946
2. Ahmed SK, Hussein S, Qurbani K, et al. Antimicrobial resistance: Impacts, challenges, and future prospects. Journal of Medicine, Surgery, and Public Health. 2024;2doi:10.1016/j.glmedi.2024.100081
3. Aransiola SA, Selvaraj B, Maddela NR. Bacterial biofilm formation and anti-biofilm strategies. Research in Microbiology. 2024;175(3)doi:10.1016/j.resmic.2023.104172
4. Laxminarayan R, Impalli I, Rangarajan R, et al. Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance. The Lancet. 2024;403(10443):2534-2550. doi:10.1016/s0140-6736(24)00878-x
5. Muteeb G, Rehman MT, Shahwan M, Aatif M. Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review. Pharmaceuticals. 2023;16(11)doi:10.3390/ph16111615
6. Cruz-Cárdenas J, Zabelina E, Guadalupe-Lanas J, Palacio-Fierro A, Ramos-Galarza C. COVID-19, consumer behavior, technology, and society: A literature review and bibliometric analysis. Technological Forecasting and Social Change. 2021;173doi:10.1016/j.techfore.2021.121179
7. Mendelson M, Lewnard JA, Sharland M, et al. Ensuring progress on sustainable access to effective antibiotics at the 2024 UN General Assembly: a target-based approach. The Lancet. 2024;403(10443):2551-2564. doi:10.1016/s0140-6736(24)01019-5
8. Costanzo V, Roviello GN. The Potential Role of Vaccines in Preventing Antimicrobial Resistance (AMR): An Update and Future Perspectives. Vaccines. 2023;11(2)doi:10.3390/vaccines11020333

9. Endale H, Mathewos M, Abdeta D. Potential Causes of Spread of Antimicrobial Resistance and Preventive Measures in One Health Perspective-A Review. Infection and Drug Resistance. 2023;Volume 16:7515-7545. doi:10.2147/idr.S428837
10. Helmy YA, Taha-Abdelaziz K, Hawwas HAE-H, et al. Antimicrobial Resistance and Recent Alternatives to Antibiotics for the Control of Bacterial Pathogens with an Emphasis on Foodborne Pathogens. Antibiotics. 2023;12(2)doi:10.3390/antibiotics12020274
11. Sachdev C, Anjankar A, Agrawal J. Self-Medication With Antibiotics: An Element Increasing Resistance. Cureus. 2022;doi:10.7759/cureus.30844
12. Essack S. Water, sanitation and hygiene in national action plans for antimicrobial resistance. Bulletin of the World Health Organization. 2021;99(08):606-608. doi:10.2471/blt.20.284232
13. Hoellein L, Kaale E, Mwalwisi YH, Schulze MH, Vetye-Maler C, Holzgrabe U. Emerging Antimicrobial Drug Resistance in Africa and Latin America: Search for Reasons. Risk Management and Healthcare Policy. 2022;Volume 15:827-843. doi:10.2147/rmhp.S205077
14. Munita JM, Arias CA, Kudva IT, Zhang Q. Mechanisms of Antibiotic Resistance. Microbiology Spectrum. 2016;4(2)doi:10.1128/microbiolspec.VMBF-0016-2015
15. Stokes JM, Lopatkin AJ, Lobritz MA, Collins JJ. Bacterial Metabolism and Antibiotic Efficacy. Cell Metabolism. 2019;30(2):251-259. doi:10.1016/j.cmet.2019.06.009
16. WHO publishes list of bacteria for which new antibiotics are urgently needed. https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed
17. Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. https://www.who.int/publications/i/item/9789240093461
18. De Oliveira DMP, Forde BM, Kidd TJ, et al. Antimicrobial Resistance in ESKAPE Pathogens. Clinical Microbiology Reviews. 2020;33(3)doi:10.1128/cmr.00181-19
19. Aljeldah MM. Antimicrobial Resistance and Its Spread Is a Global Threat. Antibiotics. 2022;11(8)doi:10.3390/antibiotics11081082
20. Zhang F, Cheng W. The Mechanism of Bacterial Resistance and Potential Bacteriostatic Strategies. Antibiotics. 2022;11(9)doi:10.3390/antibiotics11091215
21. Mirghani R, Saba T, Khaliq H, et al. Biofilms: Formation, drug resistance and alternatives to conventional approaches. AIMS Microbiology. 2022;8(3):239-277. doi:10.3934/microbiol.2022019
22. Michaelis C, Grohmann E. Horizontal Gene Transfer of Antibiotic Resistance Genes in Biofilms. Antibiotics. 2023;12(2)doi:10.3390/antibiotics12020328
23. Tao S, Chen H, Li N, Wang T, Liang W, Kaushik S. The Spread of Antibiotic Resistance Genes In Vivo Model. Canadian Journal of Infectious Diseases and Medical Microbiology. 2022;2022:1-11. doi:10.1155/2022/3348695
24. Wielders CLC, Fluit AC, Brisse S, Verhoef J, Schmitz FJ. mecA Gene Is Widely Disseminated in Staphylococcus aureus Population. Journal of Clinical Microbiology. 2002;40(11):3970-3975. doi:10.1128/jcm.40.11.3970-3975.2002
25. Ma J, Song X, Li M, et al. Global spread of carbapenem-resistant Enterobacteriaceae: Epidemiological features, resistance mechanisms, detection and therapy. Microbiological Research. 2023;266doi:10.1016/j.micres.2022.127249
26. Husna A, Rahman MM, Badruzzaman ATM, et al. Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities. Biomedicines. 2023;11(11)doi:10.3390/biomedicines11112937
27. Ramos-Martín F, D’Amelio N. Drug Resistance: An Incessant Fight against Evolutionary Strategies of Survival. Microbiology Research. 2023;14(2):507-542. doi:10.3390/microbiolres14020037
28. Gros M, Mas-Pla J, Sànchez-Melsió A, et al. Antibiotics, antibiotic resistance and associated risk in natural springs from an agroecosystem environment. Science of The Total Environment. 2023;857doi:10.1016/j.scitotenv.2022.159202
29. Du J, Guo J, Kang D, et al. New techniques and strategies in drug discovery. Chinese Chemical Letters. 2020;31(7):1695-1708. doi:10.1016/j.cclet.2020.03.028
30. Hoffman PS. Antibacterial Discovery: 21st Century Challenges. Antibiotics. 2020;9(5)doi:10.3390/antibiotics9050213
31. Stojković D, Petrović J, Carević T, Soković M, Liaras K. Synthetic and Semisynthetic Compounds as Antibacterials Targeting Virulence Traits in Resistant Strains: A Narrative Updated Review. Antibiotics. 2023;12(6)doi:10.3390/antibiotics12060963
32. Miethke M, Pieroni M, Weber T, et al. Towards the sustainable discovery and development of new antibiotics. Nature Reviews Chemistry. 2021;5(10):726-749. doi:10.1038/s41570-021-00313-1
33. Liu R, Li X, Lam KS. Combinatorial chemistry in drug discovery. Current Opinion in Chemical Biology. 2017;38:117-126. doi:10.1016/j.cbpa.2017.03.017
34. Jampilek J. Heterocycles in Medicinal Chemistry. Molecules. 2019;24(21)doi:10.3390/molecules24213839
35. Rusu A, Moga I-M, Uncu L, Hancu G. The Role of Five-Membered Heterocycles in the Molecular Structure of Antibacterial Drugs Used in Therapy. Pharmaceutics. 2023;15(11)doi:10.3390/pharmaceutics15112554
36. Pancu DF, Scurtu A, Macasoi IG, et al. Antibiotics: Conventional Therapy and Natural Compounds with Antibacterial Activity—A Pharmaco-Toxicological Screening. Antibiotics. 2021;10(4)doi:10.3390/antibiotics10040401
37. Lin X, Kück U. Cephalosporins as key lead generation beta-lactam antibiotics. Applied Microbiology and Biotechnology. 2022;106(24):8007-8020. doi:10.1007/s00253-022-12272-8
38. Gattu R, Ramesh SS, Nadigar S, D CG, Ramesh S. Conjugation as a Tool in Therapeutics: Role of Amino Acids/Peptides-Bioactive (Including Heterocycles) Hybrid Molecules in Treating Infectious Diseases. Antibiotics. 2023;12(3)doi:10.3390/antibiotics12030532
39. Tolomeu HV, Fraga CAM. Imidazole: Synthesis, Functionalization and Physicochemical Properties of a Privileged Structure in Medicinal Chemistry. Molecules. 2023;28(2)doi:10.3390/molecules28020838
40. Brishty SR, Hossain MJ, Khandaker MU, Faruque MRI, Osman H, Rahman SMA. A Comprehensive Account on Recent Progress in Pharmacological Activities of Benzimidazole Derivatives. Frontiers in Pharmacology. 2021;12doi:10.3389/fphar.2021.762807
41. Kumar N, Goel N. Recent development of imidazole derivatives as potential anticancer agents. Physical Sciences Reviews. 2023;8(10):2903-2941. doi:10.1515/psr-2021-0041
42. Poyraz S, Yıldırım M, Ersatir M. Recent pharmacological insights about imidazole hybrids: a comprehensive review. Medicinal Chemistry Research. 2024;33(6):839-868. doi:10.1007/s00044-024-03230-2
43. Andrei GȘ, Andrei BF, Roxana PR. Imidazole Derivatives and their Antibacterial Activity - A Mini-Review. Mini-Reviews in Medicinal Chemistry. 2021;21(11):1380-1392. doi:10.2174/1389557520999201209213648
44. Rossi R, Ciofalo M. An Updated Review on the Synthesis and Antibacterial Activity of Molecular Hybrids and Conjugates Bearing Imidazole Moiety. Molecules. 2020;25(21)doi:10.3390/molecules25215133
45. Gurav SS, Jadhav SR, Mali SN, Raskar SV, Lotlikar OA, Waghmode KT. Efficient Silica-OSO3H (SSA)-Catalyzed One-Pot Multicomponent Synthesis of 1,2,4,5-Tetrasubstituted 1H-Imidazoles: Molecular Docking, Antibacterial Activity, and Plausible Mechanism. Russian Journal of Organic Chemistry. 2024;60(3):530-538. doi:10.1134/s1070428024030229
46. Dziduch K, Janowska S, Andrzejczuk S, et al. Synthesis and Biological Evaluation of New Compounds with Nitroimidazole Moiety. Molecules. 2024;29(13)doi:10.3390/molecules29133023
47. Agili F. Novel Thiazole Derivatives Containing Imidazole and Furan Scaffold: Design, Synthesis, Molecular Docking, Antibacterial, and Antioxidant Evaluation. Molecules. 2024;29(7)doi:10.3390/molecules29071491
48. Mahmoodi NO, Rajabi A, Nyaki HY, Nahzomi HT. Synthesis, Characterization, Molecular Docking, and Investigation of Antibacterial Properties of New Derivatives of 1‐H‐Phenanthro [9,10‐d] Imidazole. Chemistry & Biodiversity. 2024;21(6)doi:10.1002/cbdv.202400325
49. Slassi S, Aarjane M, Amine A. Novel triazole derivatives possessing imidazole: Synthesis, spectroscopic characterization (FT-IR, NMR, UV–Vis), DFT studies and antibacterial in vitro evaluation. Journal of Molecular Structure. 2023;1276doi:10.1016/j.molstruc.2022.134788
50. Liu H, Yang S, Li T, et al. Design, Synthesis and Bioactivity Evaluation of Novel 2-(pyrazol-4-yl)-1,3,4-oxadiazoles Containing an Imidazole Fragment as Antibacterial Agents. Molecules. 2023;28(6)doi:10.3390/molecules28062442
51. Xu WB, Meng YQ, Sun J, et al. Synthesis and Antibacterial Activity Evaluation of Imidazole Derivatives Containing 6‐Methylpyridine Moiety. Chemistry & Biodiversity. 2023;20(5)doi:10.1002/cbdv.202300105
52. Saeed A, Soliman AM, Al-Taisan KM, et al. Synthesis and molecular docking of new indeno[1,2-d]imidazole, indeno[1,2-e]triazine, indeno[1,2-c]pyrazole, and indeno[1,2-b]pyrrole polycyclic compounds as antibacterial and antioxidant agents. Journal of Molecular Structure. 2023;1289doi:10.1016/j.molstruc.2023.135763
53. Sudheer Reddy V, Reddy NR, Reddy AV, Padma M, Reddy LK. Synthesis of Some New N-Substituted Imidazole Derivatives and Their In Vitro Antibacterial Investigation. Russian Journal of Bioorganic Chemistry. 2022;48(3):643-650. doi:10.1134/s1068162022030189
54. Poyraz S, Döndaş HA, Sansano JM, et al. N-Benzoylthiourea-pyrrolidine carboxylic acid derivatives bearing an imidazole moiety: Synthesis, characterization, crystal structure, in vitro ChEs inhibition, and antituberculosis, antibacterial, antifungal studies. Journal of Molecular Structure. 2023;1273doi:10.1016/j.molstruc.2022.134303
55. Aziz H, Saeed A, Khan MA, et al. Novel N‐Acyl‐1H‐imidazole‐1‐carbothioamides: Design, Synthesis, Biological and Computational Studies. Chemistry & Biodiversity. 2020;17(3)doi:10.1002/cbdv.201900509
56. Khanage S, Mohite P, Pandhare R. Synthesis and Antimicrobial Evaluation of 4-(4,5-diphenyl-1H-imidazole-2-yl)-2-methoxyphenyl-N-substituted aminoacetate Derivatives. Analytical Chemistry Letters. 2020;10(4):517-523. doi:10.1080/22297928.2020.1838319
57. Choudhari D, Salunke-Gawali S, Chakravarty D, et al. Synthesis and biological activity of imidazole based 1,4-naphthoquinones. New Journal of Chemistry. 2020;44(17):6889-6901. doi:10.1039/c9nj04339j
58. Obalı AY, Akçaalan S, Arslan E, Obalı İ. Antibacterial activities and DNA-cleavage properties of novel fluorescent imidazo-phenanthroline derivatives. Bioorganic Chemistry. 2020;100doi:10.1016/j.bioorg.2020.103885
59. Valls A, Andreu JJ, Falomir E, et al. Imidazole and Imidazolium Antibacterial Drugs Derived from Amino Acids. Pharmaceuticals. 2020;13(12)doi:10.3390/ph13120482
60. Ebenezer O, Awolade P, Koorbanally N, Singh P. New library of pyrazole–imidazo[1,2‐α]pyridine molecular conjugates: Synthesis, antibacterial activity and molecular docking studies. Chemical Biology & Drug Design. 2019;95(1):162-173. doi:10.1111/cbdd.13632